$ABCL insider trading

Over the last 12 months, AbCellera Biologics insiders reported 8 buys totaling $2.6M and no sales across SEC Form 4 filings.

$2.6M
8
4
0%
Side
$100K$1.0MJun '26JulAug
Hayden Michael R
Thermopylae Holdings Ltd.
Booth Andrew
Montalbano John S.

All insider trades

Scroll the table sideways for price, value and marks.

Aug 24, 2026Hayden Michael R▲ Buy53,613$10.64$570K+4.1%
Aug 18, 2026Montalbano John S.▲ Buy10,000$11.03$110K+4.1%
Aug 14, 2026Booth Andrew▲ Buy37,200$10.32$384K+8.3%
Aug 12, 2026Hayden Michael R▲ Buy46,387$10.37$481K+3.6%
Feb 27, 2026Thermopylae Holdings Ltd.▲ Buy38,000$3.44$131K+0.1%
Feb 27, 2026Booth Andrew▲ Buy42,600$3.42$146K+27.8%
Feb 26, 2026Thermopylae Holdings Ltd.▲ Buy177,457$3.27$580K+0.3%
Nov 26, 2025Montalbano John S.▲ Buy50,000$3.57$178K+29.2%

Every $ABCL filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? AbCellera Biologics filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ABCL feed.

ABCL Insider Trading — AbCellera Biologics Form 4 Buys & Sells | alphai